about
Early retirement and the financial assets of individuals with back problemsThe personal and national costs of mental health conditions: impacts on income, taxes, government support payments due to lost labour force participationThe impact of chronic conditions of care recipients on the labour force participation of informal carers in Australia: which conditions are associated with higher rates of non-participation in the labour force?The impact of diabetes prevention on labour force participation and income of older Australians: an economic study.The personal and national costs of lost labour force participation due to arthritis: an economic study.Changes in physical activity during a weight loss intervention and follow-up: a randomized controlled trial.Multiple chronic health conditions and their link with labour force participation and economic statusEconomic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending.The impact of diabetes on the labour force participation and income poverty of workers aged 45-64 years in Australia.The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation modelThe impact of diabetes on the labour force participation, savings and retirement income of workers aged 45-64 years in Australia.Access to general practitioner services amongst underserved Australians: a microsimulation studyThe Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.Premature retirement due to ill health and income poverty: a cross-sectional study of older workers.A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trial.Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model.Chronic health conditions and poverty: a cross-sectional study using a multidimensional poverty measure.The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD20Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.The long-term productivity impacts of all cause premature mortality in Australia.Working Beyond the Traditional Retirement Age: The Influence of Health on Australia's Older Workers.How depression and other mental health problems can affect future living standards of those out of the labour force.Quantifying the effect of early retirement on the wealth of individuals with depression or other mental illness.The long term financial impacts of CVD: living standards in retirement.Loss of income and levels of scholarship support for students on rural clinical placements: a survey of medical, nursing and allied health students.Partial and complete retirement due to ill-health among mature age Australians.Are we getting healthier as we grow older? Implications for babyboomer labor force participation.Labour force participation and the influence of having arthritis on financial status.Labor force participation and the influence of having back problems on income poverty in Australia.Costs of being a carer: labour force participation and lost earnings among older working-aged Australians.Retiring early with cardiovascular disease--impact on individual's financial assets.The impact of co-morbidities on the wealth of people with heart disease.Depression prevention, labour force participation and income of older working aged Australians: A microsimulation economic analysis.The indirect economic impacts of co-morbidities on people with depression.Labour force participation and the influence of having CVD on income poverty of older workers.Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.Association between co-morbidities and labour force participation amongst persons with back problems.Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness.
P50
Q28388132-73DB4247-257C-4CC2-A4AA-8C888AF5DCD0Q31007848-488A9B2A-A180-463D-9769-79E8556E9160Q33767183-DDC407ED-0583-40B8-8BD4-209EA6778B6CQ34120765-4F977650-7DCD-4F1F-979A-21538B787452Q34604509-47BA857A-CB71-4D81-9541-9BD43076F4BAQ34805356-EE058CB3-F5E6-4FF6-8CCC-8F110272D4A1Q35041154-AC0AD9FD-6DDB-4B15-8212-116406355C59Q35052782-CA905C42-744C-44E4-AEE3-57846AB1B138Q35107134-BABFD1B3-AEDB-4D87-9B1E-0CD88D860E9AQ35110065-63587E3D-8C7B-4CB8-AA04-14D0F39CE264Q35113101-240BCC71-094F-4D7A-B8FC-FB5197814937Q35799875-0CC9B6A2-B23C-4F54-A068-5BDD033144E1Q36220159-A44C3A5F-BC2F-4E74-A314-B1181CC326D1Q36893633-496FCCD4-E2A1-4E30-9CE1-3330B9165220Q36920875-3117D6F5-0A3E-4703-A447-E23DC00FE3C0Q37312235-91F635EF-1836-4D10-9781-77AA89AED0F2Q37352879-7E6276B1-E0FE-445F-B5E6-011BF3057A93Q37576663-152BA1DE-0EBA-4B33-889D-FC59AFD4E2C7Q38997779-7956CFC2-4502-40AC-91BA-E133C8D90B4DQ39169515-5C3142E2-69A7-412D-9175-298BF28E5409Q39438421-D3DC309B-00D2-4883-85DE-606778775FB0Q39721098-F2476B17-44D6-4D91-A62B-9CE7ABBAA339Q39787835-049AC11C-F44B-4DD1-84E8-2738C3D5D185Q39814878-676D3B29-80B1-4A88-8885-8DC4ADFCB30BQ39886340-1EB33712-C9A0-4402-916B-0A019D8AC032Q40093635-8F92A90B-2970-4639-927E-6AD505F43A81Q40180623-B8461440-8875-4A08-92FD-E2DD2C75F855Q41513290-FBDCDCE4-87BD-42D6-969B-8A9D4A719C93Q43947958-91925673-530E-4F8C-955A-73E8DB202C25Q44246616-E13D5018-E9E8-4DA3-9584-5D74499B7538Q44271478-BA34C2A2-D3F2-42C2-BE20-B2D971C65AFFQ44828994-ACAAD1C5-8CDB-4F01-AD2A-857C5F7CA4EDQ45121110-41320574-0933-412D-88DC-DD92344A9121Q45918316-E2968DAD-B123-4AC3-9133-2E7D913828AFQ46751034-74955E07-B2A3-40C0-A697-BC62135265E6Q47121111-4F114A72-EE9A-4AB2-8651-AB85F2A2DBC9Q47332319-09809623-BBFB-4B31-A469-0A5A3ECC78AEQ47681796-184586AB-F417-4273-84EB-116B886002FBQ47804535-C89318B0-0180-41F4-9E29-D6D7869C6626Q48371803-5BE77443-B613-4A9B-846B-A5932D4ED4A8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rupendra N. Shrestha
@ast
Rupendra N. Shrestha
@en
Rupendra N. Shrestha
@es
Rupendra N. Shrestha
@nl
Rupendra N. Shrestha
@sl
type
label
Rupendra N. Shrestha
@ast
Rupendra N. Shrestha
@en
Rupendra N. Shrestha
@es
Rupendra N. Shrestha
@nl
Rupendra N. Shrestha
@sl
prefLabel
Rupendra N. Shrestha
@ast
Rupendra N. Shrestha
@en
Rupendra N. Shrestha
@es
Rupendra N. Shrestha
@nl
Rupendra N. Shrestha
@sl
P106
P1153
15137487100
P31
P496
0000-0001-5455-0735